title: Ouabain stimulates slowly adapting pulmonary stretch receptors.
abstract: Ouabain, a Na(+)/K(+)-ATPase inhibitor, induces slowly adapting pulmonary stretch receptors (SARs) to discharge paradoxically. Paradoxical discharge is characterized by increased SAR activity during lung deflation coupled with silence during lung inflation. We hypothesized that over-excitation silences the SARs. Accordingly, if cyclic inflation pressure was reduced so as to lower SAR stimulation, paradoxical discharge would be prevented. In the present study, single-unit activity of SARs was recorded in anesthetized, open-chest and mechanically ventilated rabbits with positive-end-expiratory pressure (PEEP). After microinjection of ouabain into the receptive field, SAR activity initially increased and then gradually became paradoxical. During paradoxical cycling, SAR activity started and stopped abruptly, oscillating between high frequency discharge during lung deflation and silence during peak inflation. Removing PEEP reduced basal cyclic stimulation and returned the discharge pattern to normal, that is, SAR activity was highest at peak inflation pressure but silent during deflation. It is speculated that stretching SARs causes Na(+) influx, producing generator potential (GP). Normally, GP recovers by Na(+) extrusion via Na(+)/K(+)-ATPase. Ouabain inhibits the ATPase, which limits Na(+) extrusion, and thus sustains the GP. Therefore, after ouabain microinjection, lung inflation will further increase GP, causing over-excitation to silence the SARs.
authors.affiliation: Pulmonary Medicine, University of Louisville, Louisville, KY 40292, USA.
authors.forename: Edward
authors.initials: E
authors.lastname: Winner
authors.forename: Jing-Wen
authors.initials: JW
authors.lastname: Zhang
authors.forename: Mary
authors.initials: M
authors.lastname: Proctor
authors.forename: Jerry
authors.initials: J
authors.lastname: Yu
mesh_terms: D000200:Action Potentials / Q000502:physiology; D000222:Adaptation, Physiological / Q000187:drug effects*; D000818:Animals; D008168:Lung / Q000187:drug effects / Q000502:physiology*; D008297:Male; D008465:Mechanoreceptors / Q000502:physiology; D010042:Ouabain / Q000494:pharmacology*; D011661:Pulmonary Stretch Receptors / Q000187:drug effects / Q000502:physiology*; D012123:Pulmonary Ventilation / Q000187:drug effects / Q000502:physiology; D011817:Rabbits; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000502:physiology; D014630:Vagus Nerve / Q000502:physiology
chemical_list: D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase